Robert Rolleri

963 citations
34 papers · 659 · 1 hit paper · h-index 9

Impact in

    • Hidradenitis Suppurativa and Treatments
    • Dermatology and Skin Diseases
    • Chemotherapy-related skin toxicity
  • Genetics top 10%
    • Inflammatory Bowel Disease

Papers in

    • Hidradenitis Suppurativa and Treatments 14
    • Chemotherapy-related skin toxicity 2
    • Colorectal and Anal Carcinomas 3
    • Anorectal Disease Treatments and Outcomes 2

Robert Rolleri

28 papers receiving 643 citations

Robert Rolleri's Hit Papers

Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials 2024 · 87 citations
870+1Years since publication255075

Peers

Robert Rolleri
Comparison fields: 5 of 58
  • Dermatology 244
  • Genetics 229
  • Immunology 159
  • Epidemiology 139
  • Gastroenterology 21
Replace Vincenzo Bruzzese with:
Vincenzo Bruzzese Italy
Ralf Mohrbacher Germany
Joel C. Joyce United States
Nasrin Behniafard Iran
Katja Rothfuss Germany
Elizabeth Feuille United States
M Rojas-Feria Spain
Alberto J. S. Duarte Brazil
Rolf Liedholm Sweden
Gilles Macaigne France
Robert Rolleri relative to Vincenzo Bruzzese Italy Vincenzo Bruzzese's profile →
Citations per field
00.5×10×13×
Vincenzo Bruzzese · 1×
Citations per year

Countries citing papers authored by Robert Rolleri

Since Specialization
Citations

This map shows the geographic impact of Robert Rolleri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Rolleri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Rolleri more than expected).

Fields of papers citing papers by Robert Rolleri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Rolleri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Rolleri. The network helps show where Robert Rolleri may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert Rolleri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Rolleri Line = papers co-authored together Robert Rolleri links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2014166
2 2021118
3 2018103
4
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
Hit paper breakdown →
202487
5 201581
6 201832
7 201515
8 20239
9 20128
10 20127
11 20146
12 20234
13 20083
14 20133
15 20242
16 20232
17 20132
18 20251
19 20181
20 20251

About Robert Rolleri

Robert Rolleri is a scholar working on Dermatology, Surgery, Genetics, Immunology and Pathology and Forensic Medicine, having authored 34 papers that have together received 659 indexed citations. Recurring topics across this work include Hidradenitis Suppurativa and Treatments (14 papers), Psoriasis: Treatment and Pathogenesis (5 papers), Inflammatory Bowel Disease (5 papers), Colorectal and Anal Carcinomas (3 papers), Autoimmune Bullous Skin Diseases (2 papers), Chemotherapy-related skin toxicity (2 papers), Anorectal Disease Treatments and Outcomes (2 papers) and Hormonal Regulation and Hypertension (1 paper). The work is most often cited by research in Dermatology (244 citations), Genetics (229 citations), Immunology (159 citations), Epidemiology (139 citations) and Gastroenterology (21 citations). Robert Rolleri has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Enoch Bortey, William P. Forbes, William J. Sandborn, Craig Paterson, Geert D’Haens, Guangyong Zou, Margaret K. Vandervoort, Brian G. Feagan, Gregor B. E. Jemec and Reena Khanna. Their work appears in journals such as Journal of the American Academy of Dermatology, Value in Health, The American Journal of Gastroenterology, JAMA Dermatology and Inflammatory Bowel Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact